Elmiron is a drug used to treat bladder pain or discomfort associated with interstitial cystitis. The drug has come under fire recently for its potential link to serious eye damage in the forms of macular degeneration, pigmentary maulopathy, and retinal maculopathy. Although approved by the FDA in 1996, the product's label was only updated in June 2020 to inform users of potential vision problems.
When you contact us via email, website form, or phone call, our attorneys will gather some information from you. An initial call is always free.
By submitting this form, I agree that Medlin Prince & Ramezanian may collect my information and use it to provide legal guidance and assistance. Your information will not be sold, exchanged, transferred, or given to any other company for any reason whatsoever without your consent other than for the express purpose of delivering the service requested.
